Overview

Progesterone for the Treatment of COVID-19 in Hospitalized Men

Status:
Completed
Trial end date:
2020-08-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety and efficacy of progesterone for treatment of COVID-19 in hospitalized men.
Phase:
Phase 1
Details
Lead Sponsor:
Sara Ghandehari
Collaborator:
IBSA Institut Biochimique SA
Treatments:
Progesterone